All Research on Therapy Area in United Kingdom

Insight

Report
Report

The Hepatitis C Market Outlook to 2022

The hepatitis C market will experience a boom as revolutionary interferon-free regimens arrive.

Published By Datamonitor
$2800
Buy
Report
Report

The Inflammatory Bowel Disease Market Outlook to 2021

The IBD market is set to experience considerable change over the next ten years. A number of significant new product launches will reshape the market, with sales for ulcerative colitis forecast to overtake those for Crohn's disease.

Published By Datamonitor
$2800
Buy
Report
Report

The Dyslipidemia Market Outlook to 2021

In the wake of Lipitor’s patent expiry, the dyslipidemia market continues to face increasing genericization leading to falling sales in key drug classes.

Published By Datamonitor
$2800
Buy

View all Insight >>

Market Data

Interactive Model
Interactive Model

The Depression Market Forecast to 2021

The expected Q4 2013 launches of Brintellix and levomilnacipran will occur against a backdrop of a declining market.

Published By Datamonitor
$6400
Buy
Interactive Model
Interactive Model

The Hepatitis C Market Forecast to 2022

The hepatitis C market will experience a boom as revolutionary interferon-free regimens arrive.

Published By Datamonitor
$6400
Buy
Interactive Model
Interactive Model

The Inflammatory Bowel Disease Market Forecast to 2021

The IBD market is set to experience considerable change over the next ten years. A number of significant new product launches will reshape the market, with sales for ulcerative colitis forecast to overtake those for Crohn's disease.

Published By Datamonitor
$6400
Buy

View all Market Data >>

Profiles

Company Profile
Company Profile

AstraZeneca PLC

AstraZeneca PLC (AstraZeneca or 'the company') is a UK-based global biopharmaceutical company. The company is engaged in developing, manufacturing, and marketing prescription pharmaceuticals in the areas of cardiovascular, gastrointestinal, neuroscience, oncology, respiratory, inflammation, and infection. AstraZeneca operates in the Americas, Europe and Asia. The company is headquartered in London, the UK, and employed about 53,500 people as of December 31, 2012.

Published By MarketLine
$175
Buy
Company Profile
Company Profile

Vectura Group plc

Vectura Group (Vectura or 'the group') is engaged in the development of pharmaceutical therapies for the treatment of bronchopulmonary diseases. The group operates in the UK, where it is headquartered in Wiltshire. Vectura employed 216 people as of March 31, 2013.

Published By MarketLine
$175
Buy
Company Profile
Company Profile

GlaxoSmithKline Plc

GlaxoSmithKline Plc (GSK or 'the company') is a leading global provider of pharmaceutical and consumer health-related products. The company operates in more than 100 countries and its products are sold in about 150 countries. GSK is headquartered in Brentford, the UK, and employed 99,488 people as on December 31, 2012.

Published By MarketLine
$175
Buy

No help is available.